Dosage Form andStrengths: OrallyDisintegrating Tablet___________________________________Drug Interactions:Interaction withwarfarin___________________________________Contraindications,Warnings, andPrecautions: Risk ofrespiratory depression___________________________________Drug Interactions:CYP2C9 substrate___________________________________Indications and Usage:Immunization___________________________________Patient CounselingInformation: Containsmissed doseinstructions___________________________________Dosage andAdministration: Weeklydosing___________________________________Indications and Usage:Diabetes___________________________________Drug Interactions:Interaction withgrapefruit___________________________________Use in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarning___________________________________Contraindications,Warnings, andPrecautions: Black BoxWarning___________________________________Drug Interactions:CYP2C9 inhibitor___________________________________Drug Interactions:Interaction withamiodarone___________________________________Dosage Form andStrengths: Extended-release formulation___________________________________Adverse Reactions:May cause headache___________________________________Patient CounselingInformation: Advisesuse of contraception___________________________________Use in SpecificPopulations: Notrecommended duringpregnancy___________________________________Use in SpecificPopulations: Pediatricuse described___________________________________Contraindications,Warnings, andPrecautions: Risk ofQT prolongation___________________________________How Supplied/Storageand Handling:Refrigeration required___________________________________Dosage andAdministration: Twice-daily dosing___________________________________Adverse Reactions:May cause weight loss___________________________________Contraindications,Warnings, andPrecautions: Risk ofsevere rash___________________________________Dosage andAdministration: Doseadjustment required forrenal impairment___________________________________Drug Abuse andDependence:Schedule II ControlledSubstance___________________________________Patient CounselingInformation: Advisesseparation frommultivitamins___________________________________Dosage Form andStrengths: Injection___________________________________Indications and Usage:Antiviral___________________________________Use in SpecificPopulations: Geriatricuse described___________________________________Patient CounselingInformation: Must takewith food___________________________________Indications and Usage:Seizure, Epilepsy___________________________________Contraindications,Warnings, andPrecautions: Risk ofbleeding___________________________________Contraindications,Warnings, andPrecautions: Risk ofhepatotoxicity___________________________________Contraindications,Warnings, andPrecautions: Risk ofnephrotoxicity___________________________________Drug Abuse andDependence: Risk forDependence___________________________________Dosage Form andStrengths: Oralsuspension___________________________________Drug Interactions:CYP3A4 inducer___________________________________Indications and Usage:Antibiotic___________________________________Contraindications,Warnings, andPrecautions: Risk of C.difficile infection___________________________________Drug Interactions:CYP2D6 substrate___________________________________Adverse Reactions:May causedrowsiness/sedation___________________________________Indications and Usage:has 3+ FDA-approvedindications___________________________________Adverse Reactions:May cause nausea___________________________________Use in SpecificPopulations: Notrecommended duringlactation___________________________________Adverse Reactions:10+ Adverse Reactionslisted___________________________________Use in SpecificPopulations: Renalimpairment usedescribed___________________________________Drug Interactions:CYP3A4 substrate___________________________________Adverse Reactions:May cause weight gain___________________________________Patient CounselingInformation: Advisesagainst driving oroperating heavymachinery___________________________________Dosage Form andStrengths: Oral tablet___________________________________Drug Abuse andDependence:Schedule IV ControlledSubstance___________________________________Patient CounselingInformation: Advisesavoiding alcoholconsumption___________________________________Indications and Usage:Anticoagulant___________________________________Dosage Form andStrengths: Sprinkle___________________________________Use in SpecificPopulations: Hepaticimpairment usedescribed___________________________________Contraindications,Warnings, andPrecautions: Risk ofhypoglycemia___________________________________Indications and Usage:Hypertension___________________________________Indications and Usage:Pain___________________________________Indications and Usage:ADHD___________________________________Patient CounselingInformation: Adviseslimiting sun exposure___________________________________How Supplied/Storageand Handling: Store atroom temperature___________________________________Drug Interactions:CYP3A4 inhibitor___________________________________How Supplied/Storageand Handling: Protectfrom light___________________________________Dosage Form andStrengths: Oralcapsule___________________________________Dosage andAdministration: Once-daily dosing___________________________________Dosage Form andStrengths: Oralsolution___________________________________Dosage Form andStrengths: Topical___________________________________Contraindications,Warnings, andPrecautions: Risk ofserotonin syndrome___________________________________Dosage Form andStrengths: Delayed-release formulation___________________________________Drug Interactions:CYP2D6 inhibitor___________________________________Dosage Form andStrengths:Transdermal patch___________________________________Indications and Usage:Combination Therapy___________________________________Dosage andAdministration: Doseadjustment required forhepatic impairment___________________________________Indications and Usage:Depression___________________________________Dosage Form andStrengths: OrallyDisintegrating Tablet___________________________________Drug Interactions:Interaction withwarfarin___________________________________Contraindications,Warnings, andPrecautions: Risk ofrespiratory depression___________________________________Drug Interactions:CYP2C9 substrate___________________________________Indications and Usage:Immunization___________________________________Patient CounselingInformation: Containsmissed doseinstructions___________________________________Dosage andAdministration: Weeklydosing___________________________________Indications and Usage:Diabetes___________________________________Drug Interactions:Interaction withgrapefruit___________________________________Use in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarning___________________________________Contraindications,Warnings, andPrecautions: Black BoxWarning___________________________________Drug Interactions:CYP2C9 inhibitor___________________________________Drug Interactions:Interaction withamiodarone___________________________________Dosage Form andStrengths: Extended-release formulation___________________________________Adverse Reactions:May cause headache___________________________________Patient CounselingInformation: Advisesuse of contraception___________________________________Use in SpecificPopulations: Notrecommended duringpregnancy___________________________________Use in SpecificPopulations: Pediatricuse described___________________________________Contraindications,Warnings, andPrecautions: Risk ofQT prolongation___________________________________How Supplied/Storageand Handling:Refrigeration required___________________________________Dosage andAdministration: Twice-daily dosing___________________________________Adverse Reactions:May cause weight loss___________________________________Contraindications,Warnings, andPrecautions: Risk ofsevere rash___________________________________Dosage andAdministration: Doseadjustment required forrenal impairment___________________________________Drug Abuse andDependence:Schedule II ControlledSubstance___________________________________Patient CounselingInformation: Advisesseparation frommultivitamins___________________________________Dosage Form andStrengths: Injection___________________________________Indications and Usage:Antiviral___________________________________Use in SpecificPopulations: Geriatricuse described___________________________________Patient CounselingInformation: Must takewith food___________________________________Indications and Usage:Seizure, Epilepsy___________________________________Contraindications,Warnings, andPrecautions: Risk ofbleeding___________________________________Contraindications,Warnings, andPrecautions: Risk ofhepatotoxicity___________________________________Contraindications,Warnings, andPrecautions: Risk ofnephrotoxicity___________________________________Drug Abuse andDependence: Risk forDependence___________________________________Dosage Form andStrengths: Oralsuspension___________________________________Drug Interactions:CYP3A4 inducer___________________________________Indications and Usage:Antibiotic___________________________________Contraindications,Warnings, andPrecautions: Risk of C.difficile infection___________________________________Drug Interactions:CYP2D6 substrate___________________________________Adverse Reactions:May causedrowsiness/sedation___________________________________Indications and Usage:has 3+ FDA-approvedindications___________________________________Adverse Reactions:May cause nausea___________________________________Use in SpecificPopulations: Notrecommended duringlactation___________________________________Adverse Reactions:10+ Adverse Reactionslisted___________________________________Use in SpecificPopulations: Renalimpairment usedescribed___________________________________Drug Interactions:CYP3A4 substrate___________________________________Adverse Reactions:May cause weight gain___________________________________Patient CounselingInformation: Advisesagainst driving oroperating heavymachinery___________________________________Dosage Form andStrengths: Oral tablet___________________________________Drug Abuse andDependence:Schedule IV ControlledSubstance___________________________________Patient CounselingInformation: Advisesavoiding alcoholconsumption___________________________________Indications and Usage:Anticoagulant___________________________________Dosage Form andStrengths: Sprinkle___________________________________Use in SpecificPopulations: Hepaticimpairment usedescribed___________________________________Contraindications,Warnings, andPrecautions: Risk ofhypoglycemia___________________________________Indications and Usage:Hypertension___________________________________Indications and Usage:Pain___________________________________Indications and Usage:ADHD___________________________________Patient CounselingInformation: Adviseslimiting sun exposure___________________________________How Supplied/Storageand Handling: Store atroom temperature___________________________________Drug Interactions:CYP3A4 inhibitor___________________________________How Supplied/Storageand Handling: Protectfrom light___________________________________Dosage Form andStrengths: Oralcapsule___________________________________Dosage andAdministration: Once-daily dosing___________________________________Dosage Form andStrengths: Oralsolution___________________________________Dosage Form andStrengths: Topical___________________________________Contraindications,Warnings, andPrecautions: Risk ofserotonin syndrome___________________________________Dosage Form andStrengths: Delayed-release formulation___________________________________Drug Interactions:CYP2D6 inhibitor___________________________________Dosage Form andStrengths:Transdermal patch___________________________________Indications and Usage:Combination Therapy___________________________________Dosage andAdministration: Doseadjustment required forhepatic impairment___________________________________Indications and Usage:Depression___________________________________

BINGO Rx - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
  1. Dosage Form and Strengths: Orally Disintegrating Tablet _________________ __________________
  2. Drug Interactions: Interaction with warfarin _________________ __________________
  3. Contraindications, Warnings, and Precautions: Risk of respiratory depression _________________ __________________
  4. Drug Interactions: CYP2C9 substrate _________________ __________________
  5. Indications and Usage: Immunization _________________ __________________
  6. Patient Counseling Information: Contains missed dose instructions _________________ __________________
  7. Dosage and Administration: Weekly dosing _________________ __________________
  8. Indications and Usage: Diabetes _________________ __________________
  9. Drug Interactions: Interaction with grapefruit _________________ __________________
  10. Use in Specific Populations: Has reproductive toxicity/teratogenicity warning _________________ __________________
  11. Contraindications, Warnings, and Precautions: Black Box Warning _________________ __________________
  12. Drug Interactions: CYP2C9 inhibitor _________________ __________________
  13. Drug Interactions: Interaction with amiodarone _________________ __________________
  14. Dosage Form and Strengths: Extended-release formulation _________________ __________________
  15. Adverse Reactions: May cause headache _________________ __________________
  16. Patient Counseling Information: Advises use of contraception _________________ __________________
  17. Use in Specific Populations: Not recommended during pregnancy _________________ __________________
  18. Use in Specific Populations: Pediatric use described _________________ __________________
  19. Contraindications, Warnings, and Precautions: Risk of QT prolongation _________________ __________________
  20. How Supplied/Storage and Handling: Refrigeration required _________________ __________________
  21. Dosage and Administration: Twice-daily dosing _________________ __________________
  22. Adverse Reactions: May cause weight loss _________________ __________________
  23. Contraindications, Warnings, and Precautions: Risk of severe rash _________________ __________________
  24. Dosage and Administration: Dose adjustment required for renal impairment _________________ __________________
  25. Drug Abuse and Dependence: Schedule II Controlled Substance _________________ __________________
  26. Patient Counseling Information: Advises separation from multivitamins _________________ __________________
  27. Dosage Form and Strengths: Injection _________________ __________________
  28. Indications and Usage: Antiviral _________________ __________________
  29. Use in Specific Populations: Geriatric use described _________________ __________________
  30. Patient Counseling Information: Must take with food _________________ __________________
  31. Indications and Usage: Seizure, Epilepsy _________________ __________________
  32. Contraindications, Warnings, and Precautions: Risk of bleeding _________________ __________________
  33. Contraindications, Warnings, and Precautions: Risk of hepatotoxicity _________________ __________________
  34. Contraindications, Warnings, and Precautions: Risk of nephrotoxicity _________________ __________________
  35. Drug Abuse and Dependence: Risk for Dependence _________________ __________________
  36. Dosage Form and Strengths: Oral suspension _________________ __________________
  37. Drug Interactions: CYP3A4 inducer _________________ __________________
  38. Indications and Usage: Antibiotic _________________ __________________
  39. Contraindications, Warnings, and Precautions: Risk of C. difficile infection _________________ __________________
  40. Drug Interactions: CYP2D6 substrate _________________ __________________
  41. Adverse Reactions: May cause drowsiness/sedation _________________ __________________
  42. Indications and Usage: has 3+ FDA-approved indications _________________ __________________
  43. Adverse Reactions: May cause nausea _________________ __________________
  44. Use in Specific Populations: Not recommended during lactation _________________ __________________
  45. Adverse Reactions: 10+ Adverse Reactions listed _________________ __________________
  46. Use in Specific Populations: Renal impairment use described _________________ __________________
  47. Drug Interactions: CYP3A4 substrate _________________ __________________
  48. Adverse Reactions: May cause weight gain _________________ __________________
  49. Patient Counseling Information: Advises against driving or operating heavy machinery _________________ __________________
  50. Dosage Form and Strengths: Oral tablet _________________ __________________
  51. Drug Abuse and Dependence: Schedule IV Controlled Substance _________________ __________________
  52. Patient Counseling Information: Advises avoiding alcohol consumption _________________ __________________
  53. Indications and Usage: Anticoagulant _________________ __________________
  54. Dosage Form and Strengths: Sprinkle _________________ __________________
  55. Use in Specific Populations: Hepatic impairment use described _________________ __________________
  56. Contraindications, Warnings, and Precautions: Risk of hypoglycemia _________________ __________________
  57. Indications and Usage: Hypertension _________________ __________________
  58. Indications and Usage: Pain _________________ __________________
  59. Indications and Usage: ADHD _________________ __________________
  60. Patient Counseling Information: Advises limiting sun exposure _________________ __________________
  61. How Supplied/Storage and Handling: Store at room temperature _________________ __________________
  62. Drug Interactions: CYP3A4 inhibitor _________________ __________________
  63. How Supplied/Storage and Handling: Protect from light _________________ __________________
  64. Dosage Form and Strengths: Oral capsule _________________ __________________
  65. Dosage and Administration: Once-daily dosing _________________ __________________
  66. Dosage Form and Strengths: Oral solution _________________ __________________
  67. Dosage Form and Strengths: Topical _________________ __________________
  68. Contraindications, Warnings, and Precautions: Risk of serotonin syndrome _________________ __________________
  69. Dosage Form and Strengths: Delayed-release formulation _________________ __________________
  70. Drug Interactions: CYP2D6 inhibitor _________________ __________________
  71. Dosage Form and Strengths: Transdermal patch _________________ __________________
  72. Indications and Usage: Combination Therapy _________________ __________________
  73. Dosage and Administration: Dose adjustment required for hepatic impairment _________________ __________________
  74. Indications and Usage: Depression _________________ __________________